U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895940) titled 'Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitati... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894068) titled 'IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Contro... Read More
New Delhi, Oct. 27 -- Reliance shares' performance decoded: The Jio Platforms IPO was one of the most anticipated public issues of 2026. The public issue was not just pitched as a money-maker for its ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinatio... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894952) titled 'Implementing IVM for Fertility Treatment in Clinical Practice' on Oct. 07. Brief Summary: ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase Ib/II Study of Tislelizumab in Combination with Bevacizumab and Capecitabine in Advanced Sol... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pha... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More